Retired Navy SEAL & Director of Corporate Operations for Biohaven Pharmaceuticals Greg Hake

We welcome back another guest from Biohaven Pharmaceuticals to learn more about a new drug to treat migraine systems in Nurtec ODT. Veterans, particularly FEMALE veterans, are much more likely to suffer from migraines, and while the root cause isn’t immediately clear, Greg discusses how the work of Biohaven Pharmaceuticals is driven in part by a desire to help veterans treat this debilitating condition.